Otolith Labs Announces $20 Million Series A Financing by Morningside Ventures
Otolith Labs , a medical technology company developing noninvasive wearable medical devices for the treatment of vestibular disorders, today announced the closing of a $20 million Series A financing round by Morningside Ventures.
- Otolith Labs , a medical technology company developing noninvasive wearable medical devices for the treatment of vestibular disorders, today announced the closing of a $20 million Series A financing round by Morningside Ventures.
- Otolith Labs mission is to make daily living easier for the millions of Americans suffering from the symptoms of chronic vertigo and other vestibulogenic conditions.
- The team at Otolith Labs has developed a truly novel technology that could fundamentally change how chronic vertigo is treated today.
- Otolith Labs nVSM technology is designed to provide immediate symptom relief for chronic vertigo.